Blogs | Osiconet
logo
logo

Latest Financial Updates

Read latest financial news update from our blog

First Bancorp Announces Cash Dividend
First Bancorp Announces Cash Dividend

SOUTHERN PINES, N.C., March 14, 2025 /PRNewswire/ -- The Board of Directors of First Banco...

Admin | Finance | 2 days ago

read more
ABM Stock Falls Amid Cash Flow Concerns Following Earnings Report
ABM Stock Falls Amid Cash Flow Concerns Following Earnings Report

ABM Industries (ABM, Financial) experienced a notable drop in its share price, decling by...

Admin | Finance | 2 days ago

read more
Ulta Beauty (ULTA) Surges After Beating Q4 Earnings Expectations
Ulta Beauty (ULTA) Surges After Beating Q4 Earnings Expectations

Ulta Beauty (ULTA, Financial) experienced a 6.8% increase in its stock price following a s...

Admin | Finance | 2 days ago

read more
Rubrik (RUBK) Stock Surges Over 20% After Exceeding Earnings Expectations
Rubrik (RUBK) Stock Surges Over 20% After Exceeding Earnings Expectations

Rubrik, a data management company, saw its stock price increase by 20.2%. The rise followe...

Admin | Finance | 2 days ago

read more
Bearish Sentiment Towards USD Reaches 2020 Levels, BofA Survey Reveals
Bearish Sentiment Towards USD Reaches 2020 Levels, BofA Survey Reveals

A recent global investor survey by Bank of America (BofA) indicates a significant gap betw...

Admin | Finance | 2 days ago

read more
Hudson Global Inc Reports Q4 Loss of $0.20 EPS and $33.6 Million Revenue, Missing Estimates
Hudson Global Inc Reports Q4 Loss of $0.20 EPS and $33.6 Million Revenue, Missing Estimates

On March 14, 2025, Hudson Global Inc (HSON, Financial) released its 8-K filing detailing t...

Admin | Finance | 2 days ago

read more
Investor Ideas Unveils Tech and Defense Stocks to Track
Investor Ideas Unveils Tech and Defense Stocks to Track

March 14, 2025 (Investorideas.com Newswire) Investorideas.com, a global news source and ex...

Admin | Finance | 2 days ago

read more
Gain Therapeutics Doses First Participant in Phase 1b Clinical Trial of GT-02287 in Parkinson's Disease
Gain Therapeutics Doses First Participant in Phase 1b Clinical Trial of GT-02287 in Parkinson's Disease

BETHESDA, MD, Mar 14, 2025 - (ACN Newswire) - Gain Therapeutics, Inc. ( GANX), a clinical-...

Admin | Finance | 2 days ago

read more

Join Our Newsletter

join our newsletter to receive update from us

📝 View Certificate of Registration
📄 View / Download OSICONET COMPANY PDF